Formalin inactivated junin virus: Immunogenicity and protection assays
✍ Scribed by Cristina Videla; Dra. Guadalupe Carballal; Patricia Remorini; José La Torre
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 630 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
The aim of this study was to determine if Junin virus inactivated with formalin (FA) was immunogenic and able to elicit a protective response in the guinea pig. The XJ-Clone 3 strain of Junin virus grown in Vero cells was exposed to FA a t 0°C. The following inactivated antigens were prepared: A,, 0.1% FA for 50 hr; A*, 0.1% FA for 50 hr followed by concentration with polyethylene glycol (PEG); B,, 0.05% FA for 70 hr; B2, 0.05% FA for 70 hr plus PEG concentration; C, 0.1% FA for 50 hr followed by ultracentrifugation and purification by sucrose gradient. No residual infectivity was detected in any inactivated antigen either after two passages in newborn mice or by coculture with Vero cells.
After i m m u n i zat i o n , hi g hn e u t ra I i zi n g and low-immunofluorescent antibody titers were obtained in adult mice and guinea pigs, thus showing that antigenicity was preserved. However, in spite of the presence of neutralizing antibodies, guinea pigs gained no protection against challenge with the highly pathogenic XJ strain.
These results suggest that antibody amount and/or quality may be inadequate; alternatively, mechanisms other than humoral immunity, such as cellular response, not elicited by inactivated antigens may be essential for protection against Junin virus.
📜 SIMILAR VOLUMES
Hepatitis A virus (HAV) strain HM175 derived after repeated subculture of persistently infected B-SC-1 cells caused a specific cytopathic effect upon acute infection of B-SC-1 cells. The virus formed visible plaques on B-SC-1 cell monolayers after 9 to 14 days of incubation at 34 degrees C, and viru
Argentine hemorrhagic fever (Junín virus) is a human viral disease for which immune therapy proves effective, though a late neurologic syndrome is occasionally associated with the treatment. We attempted to determine in the infected marmoset Callithrix jacchus whether immune therapy leads to protect
## Abstract This study confirms the different titration patterns of murine leukemia viruses (MuLV) in permissive and non‐permissive cells reported by Hartley et al. (Lilly and Pincus, in press); the titration kinetics was one‐hit in the permissive host and two‐hit in the restrictive host. The follo